IGF-1 LR3

$169.00

You’ll be briefly redirected to Link Money, our secure ACH payment partner, to connect your bank and complete payment.– Your bank login is never visible to or stored by us – Encrypted, bank-level security – A standard, trusted payment process

Aion Aminos

Precision Peptides for Advanced Research

IGF-1 LR3 is a modified analog of insulin like growth factor 1 engineered with a 13-amino acid extension and a substitution at position 3. This structural modification reduces interaction with IGF binding proteins, resulting in an extended half life and prolonged receptor activity in laboratory models. The IGF 1 LR3 peptide is widely studied as a growth factor involved in signaling pathways related to cell proliferation, cell growth, and cellular growth processes. Research often examines how IGF-1 LR3 interacts with the IGF 1 receptor, which regulates signaling networks influenced by growth hormone, insulin, and insulin like growth factor activity. Scientific literature frequently compares long R3 IGF 1 with other analogs such as IGF 1 DES, regular IGF 1, and native IGF 1 to investigate differences in receptor activation and growth factor signaling. These studies often explore cellular models involving muscle cells, muscle tissue, and metabolic pathways associated with protein synthesis, glucose uptake, and endocrine communication. This compound is supplied as a stable, research-grade lyophilized powder suitable for controlled laboratory investigation.

Research Applications (Laboratory Use Only)

In laboratory environments, IGF-1 LR3 is commonly studied as a growth factor that activates receptor-mediated signaling pathways influencing cell proliferation, cell growth, and metabolic regulation. Researchers frequently investigate how the IGF 1 receptor responds to this analog in experimental models examining endocrine and metabolic communication.

Scientific studies often explore interactions between insulin like growth factor, growth hormone, and insulin signaling pathways. These investigations frequently examine mechanisms related to protein synthesis, glucose uptake, and cellular energy utilization in metabolic research systems.

Experimental research may also analyze biological pathways involving muscle cells, muscle tissue, and skeletal muscle signaling networks. Studies commonly investigate mechanisms associated with muscle growth, muscle hypertrophy, and structural adaptation processes in cellular models.

Additional literature explores frameworks involving recovery, muscle repair, muscle regeneration, and cellular responses to metabolic signaling within laboratory models. Some studies also reference pathways related to fat metabolism, nutrient partitioning, and theoretical metabolic frameworks involving fat loss, though these references remain confined strictly to research contexts.

Key Features

  • Compound Name: IGF-1 LR3 (Long R3 IGF-1)

  • Modified analog of insulin like growth factor 1

  • Contains a 13-amino acid extension and substitution for improved stability

  • Reduced binding to IGF binding proteins compared with regular IGF 1

  • Classified as a research-grade growth factor peptide

  • Studied in models examining cell proliferation, cell growth, and cellular growth pathways

  • Investigated in research exploring muscle cells, muscle tissue, and skeletal muscle signaling

  • Scientific literature examines relationships between growth hormone, human growth hormone, and IGF signaling networks

  • Explored in metabolic studies analyzing insulin, insulin sensitivity, and glucose uptake pathways

  • Research discussions frequently involve muscle growth, muscle hypertrophy, and muscle mass signaling pathways in cellular models

  • Supplied as lyophilized peptide powder for laboratory handling

  • Distributed for research use within the United States

  • Not intended for peptide therapy, supplementation, or human consumption

Frequently Asked Questions

IGF-1 LR3 is a modified analog of insulin like growth factor designed with structural changes that reduce binding to IGF binding proteins, resulting in prolonged receptor activity in laboratory research models.

IGF-1 LR3 contains structural modifications compared with regular IGF 1, natural IGF 1, or native IGF 1, allowing researchers to study differences in receptor signaling and growth factor activity.

Scientific literature commonly references IGF-1 LR3 in research examining growth factor signaling, cell proliferation, protein synthesis, metabolic signaling pathways, and cellular responses in muscle cells and other biological systems.

No. This peptide is supplied strictly for research use and is not intended for supplementation, peptide therapy, or human consumption.

More Peptides